Takeda Pharmaceutical announced plans to sell 21 assets, which includes its Osaka headquarters. The deals are planned to occur during late March and are being done in order to pare down the debt it incurred from its $62 billion Shire acquisition.
The drugmaker will book about $38 million as proceeds from the sale of the assets. Takeda will be transferring ownership to a newly launched subsidiary before selling it to an undisclosed buyer.
Read the Jiji Press report